(1 - 9 von 9
)
How UPMC's $1B translational sciences investment is bearing ...
www.bizjournals.com
— Matthias Kleinz, a board member of life sciences startup Novasenta and a senior vice president at UPMC Enterprises. Tim Schooley. › news
World Health Care Congress Qwoted
app.qwoted.com
Matthias Kleinz, DVM, PhD. Vice President, Translational Programs, UPMC Enterprises. Brian Klepper, PhD. Principal, Worksite Health Advisors. Sarah Krevans › event-wo...
sortiert nach Relevanz / Datum